Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Clinical trial NCT00006379 · COMPLETED

Trial details

NCT number: NCT00006379
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Small Intestine Cancer

Start date: 2000-06-01
Primary completion: 2004-01-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.